Structure Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Structure Therapeutics's estimated annual revenue is currently $18M per year.
- Structure Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Structure Therapeutics has 116 Employees.
- Structure Therapeutics grew their employee count by 66% last year.
Structure Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Structure Therapeutics?
Structure Therapeutics creates life-changing medicines for patients using advanced computational and structure-based technology. Our platform combines the latest advancements in computational chemistry, visualization of molecular interactions, and data integration to design orally available, superior medicines that overcome current limitations in biologic and peptide drugs. We are advancing our clinical-stage pipeline of differentiated, efficacious and safe treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic and pulmonary conditions. At ShouTi, our team’s deep experience with complex biological targets and mechanisms, structure-based drug design, and global drug discovery and development enables our bold vision: to design and develop world-class medicines with tremendous patient impact and broad commercial opportunity.
keywords:N/A
N/A
Total Funding
116
Number of Employees
$18M
Revenue (est)
66%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Francisco
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $16.8M | 116 | 2% | N/A |
#2 | $23.8M | 116 | -1% | N/A |
#3 | $25.5M | 116 | -8% | $35.1M |
#4 | $11.6M | 116 | 20% | N/A |
#5 | $15.1M | 116 | 71% | N/A |